BlackRock’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9M | Buy |
|
|||||
|
2025
Q1 | $18.8M | Sell |
|
|||||
|
2024
Q4 | $13.1M | Buy |
|
|||||
|
2024
Q3 | $17M | Buy |
|
|||||
|
2024
Q2 | $29.1M | Buy |
|
|||||
|
2024
Q1 | $20.2M | Buy |
|
|||||
|
2023
Q4 | $12.2M | Sell |
|
|||||
|
2023
Q3 | $8.37M | Sell |
|
|||||
|
2023
Q2 | $9.72M | Sell |
|
|||||
|
2023
Q1 | $14.2M | Sell |
|
|||||
|
2022
Q4 | $24.1M | Buy |
|
|||||
|
2022
Q3 | $39.1M | Buy |
|
|||||
|
2022
Q2 | $24.5M | Buy |
|
|||||
|
2022
Q1 | $46.6M | Buy |
|
|||||
|
2021
Q4 | $70.1M | Buy |
|
|||||
|
2021
Q3 | $82M | Buy |
|
|||||
|
2021
Q2 | $117M | Buy |
|
|||||
|
2021
Q1 | $116M | Buy |
|
|||||
|
2020
Q4 | $146M | Buy |
|
|||||
|
2020
Q3 | $86.3M | Sell |
|
|||||
|
2020
Q2 | $92.9M | Buy |
|
|||||
|
2020
Q1 | $66.3M | Sell |
|
|||||
|
2019
Q4 | $136M | Buy |
|
|||||
|
2019
Q3 | $93.9M | Buy |
|
|||||
|
2019
Q2 | $91.1M | Buy |
|
|||||
|
2019
Q1 | $119M | Sell |
|
|||||
|
2018
Q4 | $127M | Buy |
|
|||||
|
2018
Q3 | $151M | Buy |
|
|||||
|
2018
Q2 | $177M | Buy |
|
|||||
|
2018
Q1 | $97M | Buy |
|
|||||
|
2017
Q4 | $53.9M | Buy |
|
|||||
|
2017
Q3 | $46.6M | Buy |
|
|||||
|
2017
Q2 | $38.7M | Buy |
|
|||||
|
2017
Q1 | $39.8M | Buy |
|
|||||
|
2016
Q4 | $37K | Sell |
|
|||||
|
2016
Q3 | $62K | Sell |
|
|||||
|
2016
Q2 | $74K | Buy |
|
|||||
|
2016
Q1 | $41K | Buy |
|
|||||
|
2015
Q4 | $20K | Sell |
|
|||||
|
2015
Q3 | $26K | Buy |
|
|||||
|
2015
Q2 | $17K | Hold |
|
|||||
|
2015
Q1 | $8K | Hold |
|
|||||
|
2014
Q4 | $6K | Hold |
|
|||||
|
2014
Q3 | $5K | Hold |
|
|||||
|
2014
Q2 | $7K | Buy |
|